Quantum Imaging nominated for best emerging Med Tech Company award

Quantum Imaging nominated for best emerging Med Tech Company award

Quantum Imaging has been shortlisted for an OBN Award in the category of best emerging Med Tech Company for its development of ground-breaking diagnosis and detection technology.

The awards, now in their eighth year, celebrate innovation and achievement across the UK life sciences industry and recognise achievements from emerging to late stage research and development companies, as well as life sciences investors.

A judging panel of industry experts will decide the overall winner in each category, with the winning companies being announced at the OBN Awards Ceremony on Thursday 6th October at the Oxford Town Hall.

CEO of Quantum Imaging, Steve Parker, said: “We are very pleased to be shortlisted for such a prestigious industry award. 2016 has been a very successful year for us so far with award recognition, a growing team and our first product, Vitalscan, moving towards commercialisation with CE marking expected this autumn and clinical trials due to start towards the end of the year with a multicentre international clinical study”.

“Being shortlisted for this award is testament to the hard work and dedication of the whole team and I am very proud to work with such an exciting and innovative team of professionals.”